Evidence map›Paper›PMID 39000291›Full record

ArticleInternational journal of molecular sciences2024

MyD88 Signaling Accompanied by Microbiota Changes Supports Urinary Bladder Carcinogenesis.

Dora Knezović, Blanka Milić Roje, Katarina Vilović, Lucija Franković, Jelena Korac-Prlic, Janoš Terzić

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Microbiota and urinary tumor immunity: Mechanisms, therapeutic implications, and future perspectives.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dora KnezovićLaboratory for Cancer Research, University of Split School of Medicine, Šoltanska 2A, 21000 Split, Croatia.ORCID 0000-0003-3674-4493
Blanka Milić RojeLaboratory for Cancer Research, University of Split School of Medicine, Šoltanska 2A, 21000 Split, Croatia.
Katarina VilovićDepartment of Pathology, Forensic Medicine and Cytology, University Hospital of Split, Spinčićeva 1, 21000 Split, Croatia.
Lucija FrankovićLaboratory for Cancer Research, University of Split School of Medicine, Šoltanska 2A, 21000 Split, Croatia.ORCID 0000-0002-7333-8286
Jelena Korac-PrlicLaboratory for Cancer Research, University of Split School of Medicine, Šoltanska 2A, 21000 Split, Croatia.ORCID 0000-0002-7840-9979
Janoš TerzićLaboratory for Cancer Research, University of Split School of Medicine, Šoltanska 2A, 21000 Split, Croatia.

Funding

Croatian Science Foundation DOK-2021-02Croatian Science Foundation IP-2020-02-8921
6 · The paper itself

Abstract

Urinary bladder cancer (BC) inflicts a significant impairment of life quality and poses a high mortality risk.

Indexed as

Gastrointestinal MicrobiomeMice, KnockoutMyeloid Differentiation Factor 88Signal TransductionToll-Like Receptor 4Urinary Bladder NeoplasmsAnimalsButylhydroxybutylnitrosamineCarcinogenesisFemaleHumansMiceMice, Inbred C57BLMicrobiotaUrinary BladderButylhydroxybutylnitrosamineMyd88 protein, mouseMyeloid Differentiation Factor 88Tlr4 protein, mouseToll-Like Receptor 4Faecalibaculummicrobiotamyeloid differentiation factor 88Toll-like receptor 4urinary bladder neoplasms

Identifiers

PMID39000291
PMCPMC11241070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.